Bortezomib | CAS :179324-69-7 | Brand:NEWBIO |
MW:C19H25BN4O4 | MSDS: Avaiable | |
MF :384.2372 | Sample: Avaiable | |
Category: Oncology drug | Min order: 10grams | |
Quality standard:USP | Place of Origin:China | |
Introduction | is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. | |
Character | White or almost white powder | |
Applications | Pharmaceutical raw materials , Oncology drug |
Item | Specification | Results |
Description | White or off-white crystalline powder | white powder |
Solubility | Very soluble in DMSO or ethanol, up to about 200 mg/mL; poorly soluble in aqueous solution | Conforms |
Identification by NMR | THE NMR spectrum of the sample should be the same as that of reference material | Conforms |
Heavy Metal | NMT 20ppm | Conforms |
Related substances | Total impurities: NMT 1.0% Impurity A: NMT 0.3% Impurity B: NMT 0.3% Impurity C: NMT 0.3% other impurity: NMT0.1% | Conforms |
Residual solvents | Ethylacetate NMT 10000 PPM Dichloromethane NMT 2500 PPM Hexane NMT 600 PPM Acetone NMT 5000PPM Methanol NMT 3000PPM | Conforms |
Loss on drying | NMT 0.5% | 0.35% |
Optical Rotation | -41.8~-46° | -43.2° |
HPLC | â¥99.0% | 99.7% |
Conclusion: It Conforms to prescribed enterprise standard |
Wuhan Newbio Pharm-tech Co., Ltd. | |||||
S# | CAS No. | Product Name | S# | CAS No. | Product Name |
1 | 86639-52-3 | 7-Ethyl-10-Hydroxycamptothecin | 25 | 183321-74-6 | Erlotinib |
2 | 154229-18-2 | Abiraterone Acetate | 26 | 183319-69-9 | Erlotinib Hydrochloride |
3 | 50-76-0 | Actinomycin D | 27 | 159351-69-6 | Everolimus |
4 | 106941-25-7 | Adefovir | 28 | 56296-78-7 | Fluoxetine Hydrochloride |
5 | 850140-72-6 | Afatinib | 29 | 184475-55-6 | Gefitinib Hydrochloride |
6 | 330784-47-9 | Avanafil | 30 | 136572-09-3 | Irinotecan Hydrochloride TriHydrate |
7 | 319460-85-0 | Axitinib | 31 | 1441674-54-9 | Ledipasvir(Acetone) |
8 | 1421373-66-1 | AZD-9291 (Mesylate) | 32 | 191732-72-6 | Lenalidomide |
9 | 123524-52-7 | Azelnidipine | 33 | 21672 | Methotrexate |
10 | 863031-21-4 | Azilsartan Medoxomil | 34 | 76144-81-5 | Mildronate |
11 | 179324-69-7 | Bortezomib | 35 | 474645-27-7 | Monomethyl Auristatin E |
12 | 357336-20-0 | Brivaracetam | 36 | 63121-00-6 | Oxaliplatin |
13 | 842133-18-0 | Canagliflozin | 49 | 33069-62-4 | Paclitaxel |
14 | 928672-86-0 | Canagliflozin HemiHydrate | 37 | 137281-23-3 | Pemetrexed Disodium |
15 | 41575-94-4 | Carboplatin | 38 | 53123-88-9 | Rapamycin |
16 | 50935-04-1 | Carubicin | 50 | 135062-02-1 | Repaglinide |
17 | 288383-20-0 | Cediranib | 39 | 945667-22-1 | Saxagliptin Hydrate |
18 | 15663-27-1 | Cisplatin | 40 | 709031-78-7 | Saxagliptin Hydrochloride |
19 | 877399-52-5 | Crizotinib | 41 | 486460-32-6 | Sitagliptin |
20 | 171500-79-1 | Dalbavancin | 42 | 654671-77-9 | Sitagliptin Phosphate Hydrate |
21 | 114977-28-5 | Docetaxel | 44 | 85622-93-1 | Temozolomide |
22 | 148408-66-6 | Docetaxel TriHydrate | 45 | 477600-75-2 | Tofacitinib |
23 | 25316-40-9 | Doxorubicin hydrochloride | 46 | 540737-29-9 | Tofacitinib Citrate |
24 | 133040-01-4 | Eprosartan | 47 | 170791-09-0 | Trityl Candesartan Cilexetil |
Telephone | +86-027-87002705 |
Mobile | +86-13277093700 |
newbiopharmtech | |
FaceBook Page | https://www.facebook.com/newbiopharma/ |
Facebook Group | https://www.facebook.com/groups/1739616069613416/ |
Website | http://www.newbiopharm.com/ |
Online Store | http://biocar.en.made-in-china.com/ |
Product Name: Bortezomib Synonyms: VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, ...
Product Name: Bortezomib Synonyms: VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, ...
Product Name: Bortezomib Synonyms: VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, ...